Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (491-500 of 692) with videos related to

Pageof 70
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners FoundationS Peters, S Loi, F André, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 24, 2015
Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trialAlexander V Louie, Erik van Werkhoven, Hanbo Chen, et al.
ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.
The European Respiratory Journal|June 3, 2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?Jules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2013
Adherence and patients' experiences with the use of oral anticancer agentsLonneke Timmers, Christel C L M Boons, Femke Kropff, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patientsD E Ediebah, C Coens, J T Maringwa, et al.
Thorax|August 7, 2007
Recombinant human deoxyribonuclease for the treatment of acute asthma in childrenR Boogaard, F Smit, R Schornagel, et al.
Pageof 70

Showing results (491-500 of 692) with videos related to

Sort By:
Pageof 70
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2024
Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners FoundationS Peters, S Loi, F André, et al.
Lung Cancer (Amsterdam, Netherlands)|June 25, 2026
Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primaryTobias Martinot, Lydia H N Schonewille, Dina Ruano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 24, 2015
Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trialAlexander V Louie, Erik van Werkhoven, Hanbo Chen, et al.
ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.
The European Respiratory Journal|June 3, 2017
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?Jules L Derks, Robert Jan van Suylen, Erik Thunnissen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2022
Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLCSophie M Ernst, Joanne M Mankor, Job van Riet, et al.
Acta Oncologica (Stockholm, Sweden)|November 26, 2013
Adherence and patients' experiences with the use of oral anticancer agentsLonneke Timmers, Christel C L M Boons, Femke Kropff, et al.
ERJ Open Research|March 29, 2019
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisionsKarlijn Hummelink, Mirte Muller, Theodora C Linders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patientsD E Ediebah, C Coens, J T Maringwa, et al.
Thorax|August 7, 2007
Recombinant human deoxyribonuclease for the treatment of acute asthma in childrenR Boogaard, F Smit, R Schornagel, et al.
Pageof 70